- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Therapies for Autoimmune Bullous Diseases: Current Status
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-20
DOI
10.1007/s40265-018-0976-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Autoimmune Bullous Disorders in Pregnancy
- (2018) Carolyn J. Kushner et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita
- (2018) C. Prost-Squarcioni et al. BRITISH JOURNAL OF DERMATOLOGY
- A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway
- (2018) Johann Bartko et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches
- (2018) Robert Pollmann et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Pemphigus group: overview, epidemiology, mortality, and comorbidities
- (2018) Khalaf Kridin IMMUNOLOGIC RESEARCH
- Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review
- (2018) Soheil Tavakolpour et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid
- (2018) Alyson V. Ridpath et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid
- (2018) Lan Lin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus
- (2018) Volker Spindler et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increasing the Complement of Therapeutic Options in Bullous Pemphigoid
- (2018) Carolyn J. Kushner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies
- (2018) Anika Kasprick et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center
- (2018) Keshavamurthy Vinay et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comment on “Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis”
- (2018) Maglie Roberto et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts
- (2018) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab
- (2018) Marwah Adly Saleh JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of serious infections with pemphigus and pemphigoid: analysis of the Nationwide Inpatient Sample
- (2018) Z. Ren et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis
- (2018) Farzan Solimani et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Association Between Pemphigus and Neurologic Diseases
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Coexistent Solid Malignancies in Pemphigus
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
- (2018) Aniek Lamberts et al. Frontiers in Immunology
- Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study
- (2017) Caiyun You et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid
- (2017) Masayuki Amagai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Desmoglein 3-Reactive B Cells “Hiding” in Pemphigus Lesions
- (2017) Hayato Takahashi JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis
- (2017) Huijie Yuan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016
- (2017) Enno Schmidt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Venous thromboembolism in patients with pemphigus: A cohort study
- (2017) Yael Anne Leshem et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab
- (2017) Lauren N. Albers et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis
- (2017) Lihi Atzmony et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab
- (2017) C. Baykal et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers
- (2017) Manuel Valdebran et al. JAMA Dermatology
- Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid
- (2017) Laura Sowerby et al. JAMA Dermatology
- Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity
- (2017) Nina van Beek et al. JAMA Dermatology
- Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion
- (2017) Mayumi Kamaguchi et al. Frontiers in Immunology
- A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: IsHLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
- (2017) K. T. Amber et al. HLA
- Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome
- (2017) Delphine Giusti et al. Scientific Reports
- Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.
- (2016) Z. Ren et al. BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus
- (2016) Soheil Tavakolpour Dermatologic Therapy
- APRIL levels are associated with disease activity in human chronic graft-versus-host disease
- (2016) F. Chasset et al. HAEMATOLOGICA
- First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up
- (2016) A. Razzaque Ahmed et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- High serum APRIL levels strongly correlate with disease severity in pediatric atopic eczema
- (2016) Mohamed H. Mohamed Ezzat et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Long-term results of rituximab–intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy
- (2016) Ayse Oktem et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Increase of interleukin-10-producing B cells associated with long-term remission after i.v. immunoglobulin treatment for pemphigus
- (2016) Miho Kabuto et al. JOURNAL OF DERMATOLOGY
- Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP)
- (2016) Alexander Maley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pemphigoid gestationis: a successful preventive treatment by rituximab
- (2016) M. Tourte et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature
- (2016) G. Balakirski et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Increased risk of venous thromboembolism in patients with bullous pemphigoid
- (2016) Paolo Bucciarelli et al. THROMBOSIS AND HAEMOSTASIS
- APRIL levels are associated with disease activity in human chronic graft-versus-host disease
- (2016) F. Chasset et al. HAEMATOLOGICA
- Costs of Care for Hospitalization for Pemphigus in the United States
- (2016) Derek Hsu et al. JAMA Dermatology
- Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
- (2015) H Wang et al. ACTA DERMATO-VENEREOLOGICA
- Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
- (2015) Susanne Radonjic-Hoesli et al. Annual Review of Pharmacology and Toxicology
- Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid
- (2015) Michael Mersmann et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
- (2015) C. Feliciani et al. BRITISH JOURNAL OF DERMATOLOGY
- Pemphigus and associated comorbidities: a cross-sectional study
- (2015) K. Heelan et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid
- (2015) Kelly N. Messingham et al. EXPERIMENTAL DERMATOLOGY
- Rituximab preserves vision in ocular mucous membrane pemphigoid
- (2015) Anne Rübsam et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pemphigoiderkrankungen
- (2015) O.N. Horváth et al. HAUTARZT
- Pemphigus
- (2015) R. Eming HAUTARZT
- Molekulare Diagnostik der blasenbildenden Autoimmundermatosen
- (2015) K. Hoffmann et al. HAUTARZT
- Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris
- (2015) R. Asothai et al. IMMUNOBIOLOGY
- Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis
- (2015) Tegan Nguyen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris
- (2015) Yumay Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab
- (2015) Kara Heelan et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- In vivo analysis of IgE autoantibodies in bullous pemphigoid: A study of 100 cases
- (2015) Reine Moriuchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata
- (2015) Yu-Mei Han et al. JOURNAL OF DERMATOLOGY
- Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita
- (2015) Misa Hirose et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
- (2015) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA
- (2015) K.T. Amber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-Term Remissions in Recalcitrant Pemphigus Vulgaris
- (2015) A. Razzaque Ahmed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
- (2015) Nathaniel Washburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs
- (2015) Benjamin M. Fiebiger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune response in pemphigus and beyond: progresses and emerging concepts
- (2015) Giovanni Di Zenzo et al. Seminars in Immunopathology
- Successful Treatment of Mucous Membrane Pemphigoid with the Anti-CD-20 Antibody Rituximab
- (2014) T Schumann et al. ACTA DERMATO-VENEREOLOGICA
- Remission of Bullous Pemphigoid after Rituximab Treatment in a Psoriasis Patient on Regular Low-dose Methotrexate
- (2014) T Wang et al. ACTA DERMATO-VENEREOLOGICA
- Molecular Diagnosis in Autoimmune Skin Blistering Conditions
- (2014) J.V. Otten et al. CURRENT MOLECULAR MEDICINE
- Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins
- (2014) Jana Langenhan et al. EXPERIMENTAL DERMATOLOGY
- B-cell activating factor detected on both naïve and memory B cells in bullous pemphigoid
- (2014) Hua Qian et al. EXPERIMENTAL DERMATOLOGY
- A population-based study of the association between bullous pemphigoid and neurologic disorders
- (2014) Katherine E. Brick et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Omalizumab therapy for bullous pemphigoid
- (2014) Kenneth K. Yu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of bullous pemphigoid with adjuvant immunoadsorption: A case series
- (2014) Michael Kasperkiewicz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
- (2014) K.T. Amber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid
- (2014) A. Tedeschi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Type I and type II Fc receptors regulate innate and adaptive immunity
- (2014) Andrew Pincetic et al. NATURE IMMUNOLOGY
- Human Eosinophils Express the High Affinity IgE Receptor, FcεRI, in Bullous Pemphigoid
- (2014) Kelly N. Messingham et al. PLoS One
- Expression of TNF-α, April and BCMA in Behcet’s Disease
- (2014) Olfat G. Shaker et al. Journal of Immunology Research
- Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells
- (2013) A. S. W. Tjon et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris
- (2013) Kyle T. Amber et al. EXPERIMENTAL DERMATOLOGY
- Differential expression of BAFF and its receptors in discoid lupus erythematosus patients
- (2013) Benjamin F. Chong et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1-Mammalian Target of Rapamycin Axis
- (2013) S. Othy et al. JOURNAL OF IMMUNOLOGY
- Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
- (2013) Russell P. Hall et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication
- (2013) M. Kolesnik et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- General mechanism for modulating immunoglobulin effector function
- (2013) P. Sondermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity
- (2013) Ikuko Ueda-Hayakawa et al. RHEUMATOLOGY
- Detection of IgG and IgE reactivity to BP180 using the ISAC®microarray system
- (2012) D. Pomponi et al. BRITISH JOURNAL OF DERMATOLOGY
- Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease
- (2012) A. V. Marzano et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses
- (2012) Luca Fania et al. CLINICAL IMMUNOLOGY
- IVIg-mediated inhibition of antigen presentation: Predominant role of naturally occurring cationic IgG
- (2012) Patrick Trépanier et al. CLINICAL IMMUNOLOGY
- Adjuvant Treatment of Recalcitrant Bullous Pemphigoid with Immunoadsorption
- (2012) P.A. Müller et al. DERMATOLOGY
- Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models
- (2012) Hideyuki Ujiie et al. EXPERIMENTAL DERMATOLOGY
- Functional Characterization of an IgE-Class Monoclonal Antibody Specific for the Bullous Pemphigoid Autoantigen, BP180
- (2012) Kelly A.N. Messingham et al. HYBRIDOMA
- In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
- (2012) Leslie P. Cousens et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Inhibitory Effect of IVIG on IL-17 Production by Th17 Cells is Independent of Anti-IL-17 Antibodies in the Immunoglobulin Preparations
- (2012) Mohan S. Maddur et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site
- (2012) Osamu Fukuchi et al. JOURNAL OF DERMATOLOGY
- The expression of BAFF in the muscles of patients with dermatomyositis
- (2012) Ahmi Baek et al. JOURNAL OF NEUROIMMUNOLOGY
- A Case of Recalcitrant Epidermolysis Bullosa Acquisita Responsive to Rituximab Therapy
- (2012) Sophia K. McKinley et al. PEDIATRIC DERMATOLOGY
- Immunoadsorption in Dermatology
- (2012) Damian Meyersburg et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Targeting B Cells and Antibody in Transplantation
- (2011) M. R. Clatworthy AMERICAN JOURNAL OF TRANSPLANTATION
- Rituximab for Severe Mucous Membrane Pemphigoid
- (2011) Michael Hertl ARCHIVES OF DERMATOLOGY
- Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis
- (2011) S. Yayli et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
- (2011) M. Kasperkiewicz et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy
- (2011) R.J. Feldman et al. BRITISH JOURNAL OF DERMATOLOGY
- Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
- (2011) M. Behzad et al. BRITISH JOURNAL OF DERMATOLOGY
- Low-dose rituximab is effective in pemphigus
- (2011) B. Horváth et al. BRITISH JOURNAL OF DERMATOLOGY
- Pemphigoid Gestationis: Current Management
- (2011) Lizbeth R.A. Intong et al. DERMATOLOGIC CLINICS
- Lesional Th17 cells and regulatory T cells in bullous pemphigoid
- (2011) Masataka Arakawa et al. EXPERIMENTAL DERMATOLOGY
- Therapieresistentes Anti-Laminin-332-Schleimhautpemphigoid
- (2011) A. Recke et al. HAUTARZT
- Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris
- (2011) T. Yokoyama et al. INTERNATIONAL IMMUNOLOGY
- Eosinophil extracellular DNA traps in skin diseases
- (2011) Dagmar Simon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Glucocorticosteroid-resistant pemphigoid gestationis: Successful treatment with adjuvant immunoadsorption
- (2011) Lilia WESTERMANN et al. JOURNAL OF DERMATOLOGY
- Successful treatment of epidermolysis bullosa acquisita with rituximab therapy
- (2011) Jong Hoon KIM et al. JOURNAL OF DERMATOLOGY
- Dominant Th2 Differentiation of Human Regulatory T Cells upon Loss of FOXP3 Expression
- (2011) L. Hansmann et al. JOURNAL OF IMMUNOLOGY
- FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid
- (2011) K. N. Messingham et al. JOURNAL OF IMMUNOLOGY
- Enhancement of the Affinity of Glucocorticoid Receptors as a Mechanism Underlying the Steroid-sparing Effect of Intravenous Immunoglobulin: Figure 1.
- (2011) ANASTAS PASHOV et al. JOURNAL OF RHEUMATOLOGY
- Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients
- (2011) Michael Kasperkiewicz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
- (2011) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up
- (2011) A.R. Ahmed et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Immunoadsorption in dermatology
- (2010) Enno Schmidt et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms
- (2010) Masato Watanabe et al. CYTOKINE & GROWTH FACTOR REVIEWS
- sHLA-I Contamination, A Novel Mechanism to Explain Ex Vivo/In Vitro Modulation of IL-10 Synthesis and Release in CD8+ T Lymphocytes and in Neutrophils Following Intravenous Immunoglobulin Infusion
- (2010) Massimo Ghio et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies
- (2010) Margarita Lolis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease
- (2010) Yaohan Li et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients
- (2010) S. Lourari et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris
- (2010) A.R. Ahmed et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combination of Rituximab and Intravenous Immunoglobulin for Recalcitrant Ocular Cicatricial Pemphigoid
- (2010) C. Stephen Foster et al. OPHTHALMOLOGY
- Intravenous Immunoglobulins Promote Skin Allograft Acceptance by Triggering Functional Activation of CD4+Foxp3+ T cells
- (2010) Thanyalak Tha-In et al. TRANSPLANTATION
- Efficacité du rituximab dans une pemphigoïde bulleuse en échec thérapeutique
- (2009) Z. Reguiaï et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Rituximab in Severe Pemphigus
- (2009) Enno Schmidt et al. Annals of the New York Academy of Sciences
- Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
- (2009) Ji Yang et al. ARTHRITIS AND RHEUMATISM
- Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation
- (2009) E. Aubin et al. BLOOD
- Refractory epidermolysis bullosa acquisita: successful treatment with rituximab
- (2009) M. Saha et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3
- (2009) Angela Nagel et al. CLINICAL IMMUNOLOGY
- Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
- (2009) Richard L. Wasserman et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Intravenous immunoglobulin up-regulates the expression of the inhibitory FcγIIB receptor on B cells
- (2009) Kalina A Nikolova et al. IMMUNOLOGY AND CELL BIOLOGY
- Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
- (2009) Janet A. Fairley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid
- (2009) Kelly A.N. Messingham et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris
- (2009) Angela Nagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus
- (2009) Masayuki Amagai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of Juvenile Pemphigus Vulgaris with Intravenous Immunoglobulin Therapy
- (2009) Adam Asarch et al. PEDIATRIC DERMATOLOGY
- Impaired inhibitory Fc receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy
- (2009) B. Tackenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Intravenous Immunoglobulin Therapy on Serum Levels of IgG1 and IgG4 Antidesmoglein 1 and Antidesmoglein 3 Antibodies in Pemphigus Vulgaris
- (2008) Michelle G. Green et al. ARCHIVES OF DERMATOLOGY
- Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: Implications for the clinical use of intravenous immunoglobulins (IVIg)
- (2008) Stephan von Gunten et al. AUTOIMMUNITY REVIEWS
- Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
- (2008) R. Stasi et al. BLOOD
- BAFF is elevated in serum of patients with psoriasis: association with disease activity
- (2008) S. Samoud-El Kissi et al. BRITISH JOURNAL OF DERMATOLOGY
- IgE autoantibodies against the intracellular domain of BP180
- (2008) S.K. Dresow et al. BRITISH JOURNAL OF DERMATOLOGY
- Rituximab: Beyond Simple B Cell Depletion
- (2008) A. Kessel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy
- (2008) Derin B. Keskin et al. CYTOKINE
- Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases
- (2008) Michael Hertl et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Rituximab Exerts a Dual Effect in Pemphigus Vulgaris
- (2008) Rüdiger Eming et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus
- (2008) Annette Czernik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis
- (2007) A. Ephrem et al. BLOOD
- Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid
- (2007) Nobuko Ishiura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now